Wells Fargo’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.3K Sell
46,540
-70,177
-60% -$59.2K ﹤0.01% 5559
2025
Q4
$91.4K Buy
116,717
+5,658
+5% +$4.64K ﹤0.01% 5418
2025
Q3
$80.1K Sell
111,059
-166,329
-60% -$754K ﹤0.01% 5416
2025
Q2
$1.41M Buy
277,388
+109,169
+65% +$430K ﹤0.01% 3483
2025
Q1
$508K Buy
168,219
+62,450
+59% +$228K ﹤0.01% 4090
2024
Q4
$383K Buy
105,769
+103,269
+4,131% +$313K ﹤0.01% 4362
2024
Q3
$4.4K Buy
2,500
+1,000
+67% +$1.82K ﹤0.01% 5941
2024
Q2
$2.34K Sell
1,500
-412
-22% -$717 ﹤0.01% 5989
2024
Q1
$3.73K Buy
1,912
+7
+0.4% +$12 ﹤0.01% 5937
2023
Q4
$2.69K Buy
1,905
+30
+2% +$38 ﹤0.01% 6049
2023
Q3
$2.96K Sell
1,875
-16
-0.8% -$30 ﹤0.01% 6041
2023
Q2
$4.08K Buy
1,891
+37
+2% +$81 ﹤0.01% 6106
2023
Q1
$3.89K Buy
1,854
+159
+9% +$348 ﹤0.01% 6104
2022
Q4
$3.71K Buy
1,695
+9
+0.5% +$21 ﹤0.01% 5854
2022
Q3
$6K Buy
1,686
+11
+0.7% +$37 ﹤0.01% 5870
2022
Q2
$4K Buy
1,675
+16
+1% +$58 ﹤0.01% 6123
2022
Q1
$9K Hold
1,659
﹤0.01% 6325
2021
Q4
$12K Buy
1,659
+71
+4% +$593 ﹤0.01% 6490
2021
Q3
$15K Buy
1,588
+1,491
+1,537% +$8.92K ﹤0.01% 6079
2021
Q2
$0 Buy
97
+35
+56% +$149 ﹤0.01% 7615
2021
Q1
$0 Hold
62
﹤0.01% 7537
2020
Q4
$0 Buy
62
+7
+13% +$26 ﹤0.01% 7176
2020
Q3
$0 Buy
55
+2
+4% +$8 ﹤0.01% 7066
2020
Q2
$0 Buy
53
+7
+15% +$25 ﹤0.01% 6979
2020
Q1
$0 Buy
+46
New +$199 ﹤0.01% 6977
2018
Q2
Sell
-1,411
Closed -$52K 6642
2018
Q1
$52K Buy
1,411
+88
+7% +$4.12K ﹤0.01% 5555
2017
Q4
$65K Buy
+1,323
New +$81.3K ﹤0.01% 5465
2016
Q2
Sell
-33
Closed -$2K 6385
2016
Q1
$2K Buy
33
+32
+3,200% +$2.43K ﹤0.01% 6049
2015
Q4
$0 Sell
1
-1
-50% -$142 ﹤0.01% 6483
2015
Q3
$0 Sell
2
-20
-91% -$4.56K ﹤0.01% 6516
2015
Q2
$6K Buy
+22
New +$6.83K ﹤0.01% 5971

Other funds holding ATYR